Refractory, accelerated phase Chronic myeloid leukemia
Drug | Drug Name | Drug Description |
---|---|---|
DB04865 | Omacetaxine mepesuccinate | A cephalotaxine used in the treatment of Chronic Myeloid Leukemia (CML) that is intolerant to or resistant to two or more tyrosine kinase inhibitors. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB04865 | Omacetaxine mepesuccinate | 50S ribosomal protein L2 | target |
DB04865 | Omacetaxine mepesuccinate | 60S ribosomal protein L3 | target |
Drug | Drug Name | Phase | Status | Count |
---|